Literature DB >> 28101886

Incident alopecia areata and vitiligo in adult women with atopic dermatitis: Nurses' Health Study 2.

A M Drucker1,2, J M Thompson1, W-Q Li1,3, E Cho1,3,4, T Li4, E Guttman-Yassky5,6, A A Qureshi1,2,3,4.   

Abstract

We aimed to determine the risk of alopecia areata (AA) and vitiligo associated with atopic dermatitis (AD) in a large cohort of US women, the Nurses' Health Study 2. We used logistic regression to calculate age- and multivariate-adjusted odds ratios to determine the risk of incident AA and vitiligo associated with AD diagnosed in or before 2009. A total of 87 406 and 87 447 participants were included in the AA and vitiligo analyses, respectively. A history of AD in 2009 was reported in 11% of participants. There were 147 incident cases of AA and 98 incident cases of vitiligo over 2 years of follow-up. AD was associated with increased risk of developing AA (OR 1.80, 95% CI 1.18-2.76) and vitiligo (OR 2.14, 95% CI 1.29-3.54) in multivariate models. In this study of US women, AD was associated with increased risk of incident vitiligo and AA in adulthood.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  alopecia areata; atopic dermatitis; comorbidities; epidemiology; vitiligo

Mesh:

Year:  2017        PMID: 28101886      PMCID: PMC5567803          DOI: 10.1111/all.13128

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  15 in total

1.  Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism.

Authors:  Emma Guttman-Yassky; Benjamin Ungar; Shinji Noda; Maria Suprun; Anjali Shroff; Riana Dutt; Saakshi Khattri; Michelle Min; Yasaman Mansouri; Xiuzhong Zheng; Yeriel D Estrada; Giselle K Singer; Mayte Suarez-Farinas; James G Krueger; Mark G Lebwohl
Journal:  J Allergy Clin Immunol       Date:  2015-11-20       Impact factor: 10.793

2.  Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing.

Authors:  Mayte Suárez-Fariñas; Benjamin Ungar; Shinji Noda; Anjali Shroff; Yasaman Mansouri; Judilyn Fuentes-Duculan; Annette Czernik; Xiuzhong Zheng; Yeriel D Estrada; Hui Xu; Xiangyu Peng; Avner Shemer; James G Krueger; Mark G Lebwohl; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2015-08-24       Impact factor: 10.793

3.  Prevalence of atopic dermatitis in Italian schoolchildren: factors affecting its variation.

Authors:  Luigi Naldi; Fabio Parazzini; Silvano Gallus
Journal:  Acta Derm Venereol       Date:  2009       Impact factor: 4.437

4.  Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study.

Authors:  Szu-Ying Chu; Yi-Ju Chen; Wei-Cheng Tseng; Ming-Wei Lin; Tzeng-Ji Chen; Chian-Yaw Hwang; Chih-Chiang Chen; Ding-Dar Lee; Yun-Ting Chang; Wen-Jen Wang; Han-Nan Liu
Journal:  J Am Acad Dermatol       Date:  2011-05-25       Impact factor: 11.527

5.  Autoimmune diseases in adults with atopic dermatitis.

Authors:  Yuki M F Andersen; Alexander Egeberg; Gunnar H Gislason; Lone Skov; Jacob P Thyssen
Journal:  J Am Acad Dermatol       Date:  2016-10-11       Impact factor: 11.527

6.  Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis.

Authors:  Saakshi Khattri; Patrick M Brunner; Sandra Garcet; Robert Finney; Steven R Cohen; Margeaux Oliva; Riana Dutt; Judilyn Fuentes-Duculan; Xiuzhong Zheng; Xuan Li; Kathleen M Bonifacio; Norma Kunjravia; Israel Coats; Inna Cueto; Patricia Gilleaudeau; Mary Sullivan-Whalen; Mayte Suárez-Fariñas; James G Krueger; Emma Guttman-Yassky
Journal:  Exp Dermatol       Date:  2016-08-09       Impact factor: 3.960

Review 7.  New pathogenic and therapeutic paradigms in atopic dermatitis.

Authors:  Dana Malajian; Emma Guttman-Yassky
Journal:  Cytokine       Date:  2014-12-23       Impact factor: 3.861

Review 8.  Association of Vitiligo and Alopecia Areata With Atopic Dermatitis: A Systematic Review and Meta-analysis.

Authors:  Girish C Mohan; Jonathan I Silverberg
Journal:  JAMA Dermatol       Date:  2015-05       Impact factor: 10.282

9.  History of atopy or autoimmunity increases risk of alopecia areata.

Authors:  Nazila Barahmani; Matthew B Schabath; Madeleine Duvic
Journal:  J Am Acad Dermatol       Date:  2009-07-16       Impact factor: 11.527

10.  Alopecia areata and autoimmunity: a clinical study.

Authors:  Emy Abi Thomas; R S Kadyan
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

View more
  7 in total

1.  Diagnosis validation and clinical characterization of atopic dermatitis in Nurses' Health Study 2.

Authors:  A M Drucker; E Cho; W-Q Li; C A Camargo; T Li; A A Qureshi
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-02-18       Impact factor: 6.166

Review 2.  JAK Inhibitors for Treatment of Alopecia Areata.

Authors:  Eddy H C Wang; Brigitte N Sallee; Christina I Tejeda; Angela M Christiano
Journal:  J Invest Dermatol       Date:  2018-07-26       Impact factor: 8.551

Review 3.  The convergence theory for vitiligo: A reappraisal.

Authors:  Roopal V Kundu; Julia M Mhlaba; Stephanie M Rangel; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2018-06-28       Impact factor: 3.960

Review 4.  Overlapping Features of Psoriasis and Atopic Dermatitis: From Genetics to Immunopathogenesis to Phenotypes.

Authors:  Ya-Chu Tsai; Tsen-Fang Tsai
Journal:  Int J Mol Sci       Date:  2022-05-15       Impact factor: 6.208

Review 5.  The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm.

Authors:  Yael Renert-Yuval; Emma Guttman-Yassky
Journal:  Adv Ther       Date:  2017-06-23       Impact factor: 3.845

6.  Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata.

Authors:  Kumutnart Chanprapaph; Thipprapai Mahasaksiri; Chaninan Kositkuljorn; Kanchana Leerunyakul; Poonkiat Suchonwanit
Journal:  J Inflamm Res       Date:  2021-09-22

Review 7.  Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect.

Authors:  Thanaporn Ratchataswan; Tina M Banzon; Jacob P Thyssen; Stephan Weidinger; Emma Guttman-Yassky; Wanda Phipatanakul
Journal:  J Allergy Clin Immunol Pract       Date:  2021-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.